US EditionPublished • loading... • Updated
Forget AI Stocks: This Biotech Could Cure What AI Can't Touch
Summary by The Motley Fool
1 Articles
1 Articles
Forget AI Stocks: This Biotech Could Cure What AI Can't Touch
Key PointsCRISPR Therapeutics is targeting multiple difficult-to-treat diseases with several candidates. The company's shares could soar if it delivers consistent clinical and regulatory progress.However, the stock is somewhat risky as the business is mostly in its clinical stages.10 stocks we like better than CRISPR Therapeutics › Artificial intelligence (AI) is slowly changing and reshaping industries, from banking to telecom. The technology w…
·Alexandria, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left1Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium
